Literature DB >> 22302548

Accelerated cortical atrophy in cognitively normal elderly with high β-amyloid deposition.

G Chételat1, V L Villemagne, N Villain, G Jones, K A Ellis, D Ames, R N Martins, C L Masters, C C Rowe.   

Abstract

OBJECTIVE: Given the recent and growing interest in the concepts of prodromal and presymptomatic Alzheimer disease, it is crucial to determine whether the presence of β-amyloid (Aβ) in the brain of asymptomatic elderly individuals is a pathologic condition associated with accelerated neuronal and synaptic loss. The aim of the present study was to assess whether Aβ influences the rate of atrophy in cognitively normal elderly individuals.
METHODS: Seventy-four healthy elderly individuals underwent an MRI scan and a 11C-Pittsburgh compound B (PiB) PET scan at baseline and a second MRI scan 18 months later. Voxel-wise analyses were performed using maps of annual rate of atrophy generated from the serial MRI scans, including comparison between individuals with high vs low neocortical PiB and correlation with baseline neocortical PiB.
RESULTS: The rate of atrophy was significantly higher in the normal elderly individuals with high PiB compared with those with low PiB and was significantly correlated with baseline neocortical PiB, with the highest significance in the temporal neocortex and the posterior cingulate cortex.
CONCLUSIONS: Our findings show that the presence of Aβ in the brain, known to occur in about one-third of asymptomatic elderly individuals, is actually a pathologic state associated with accelerated atrophy. They also suggest that therapy aimed to reduce the neurodegenerative process should be commenced in presymptomatic individuals with high PiB.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22302548     DOI: 10.1212/WNL.0b013e318246d67a

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  82 in total

1.  Mapping 3-year changes in gray matter and metabolism in Aβ-positive nondemented subjects.

Authors:  Miguel Ángel Araque Caballero; Matthias Brendel; Andreas Delker; Jinyi Ren; Axel Rominger; Peter Bartenstein; Martin Dichgans; Michael W Weiner; Michael Ewers
Journal:  Neurobiol Aging       Date:  2015-08-18       Impact factor: 4.673

2.  Brain structural substrates of cognitive procedural learning in alcoholic patients early in abstinence.

Authors:  Ludivine Ritz; Shailendra Segobin; Anne Pascale Le Berre; Coralie Lannuzel; Céline Boudehent; François Vabret; Francis Eustache; Anne Lise Pitel; Hélène Beaunieux
Journal:  Alcohol Clin Exp Res       Date:  2014-08       Impact factor: 3.455

Review 3.  Three dimensions of the amyloid hypothesis: time, space and 'wingmen'.

Authors:  Erik S Musiek; David M Holtzman
Journal:  Nat Neurosci       Date:  2015-06       Impact factor: 24.884

4.  The transitional association between β-amyloid pathology and regional brain atrophy.

Authors:  Philip S Insel; Niklas Mattsson; Michael C Donohue; R Scott Mackin; Paul S Aisen; Clifford R Jack; Leslie M Shaw; John Q Trojanowski; Michael W Weiner
Journal:  Alzheimers Dement       Date:  2014-12-09       Impact factor: 21.566

5.  Effects of cerebrospinal fluid proteins on brain atrophy rates in cognitively healthy older adults.

Authors:  Niklas Mattsson; Philip Insel; Rachel Nosheny; John Q Trojanowski; Leslie M Shaw; Clifford R Jack; Duygu Tosun; Michael Weiner
Journal:  Neurobiol Aging       Date:  2013-10-01       Impact factor: 4.673

6.  Biomarkers for the clinical evaluation of the cognitively impaired elderly: amyloid is not enough.

Authors:  Linda K McEvoy; James B Brewer
Journal:  Imaging Med       Date:  2012-06

7.  In vivo hippocampal subfield shape related to TDP-43, amyloid beta, and tau pathologies.

Authors:  Veronika Hanko; Alexandra C Apple; Kathryn I Alpert; Kristen N Warren; Julie A Schneider; Konstantinos Arfanakis; David A Bennett; Lei Wang
Journal:  Neurobiol Aging       Date:  2018-10-25       Impact factor: 4.673

Review 8.  Using Pittsburgh Compound B for in vivo PET imaging of fibrillar amyloid-beta.

Authors:  Ann D Cohen; Gil D Rabinovici; Chester A Mathis; William J Jagust; William E Klunk; Milos D Ikonomovic
Journal:  Adv Pharmacol       Date:  2012

9.  Alzheimer's disease neurodegenerative biomarkers are associated with decreased cognitive function but not β-amyloid in cognitively normal older individuals.

Authors:  Miranka Wirth; Cindee M Madison; Gil D Rabinovici; Hwamee Oh; Susan M Landau; William J Jagust
Journal:  J Neurosci       Date:  2013-03-27       Impact factor: 6.167

Review 10.  Is amyloid-β harmful to the brain? Insights from human imaging studies.

Authors:  William Jagust
Journal:  Brain       Date:  2015-11-27       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.